Cargando…
Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux
Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection...
Autores principales: | Lightfoot, Michelle, Bilgutay, Aylin N., Tollin, Noah, Eisenberg, Scott, Weiser, Jake, Bryan, Leah, Smith, Edwin, Elmore, James, Scherz, Hal, Kirsch, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776605/ https://www.ncbi.nlm.nih.gov/pubmed/31612121 http://dx.doi.org/10.3389/fped.2019.00392 |
Ejemplares similares
-
Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/Hyaluronic Acid in Children
por: Cerwinka, Wolfgang H., et al.
Publicado: (2008) -
A Comparison of Calcium Hydroxyapatite and Dextranomer/Hyaluronic Acid for the Endoscopic Treatment of Vesicoureteral Reflux
por: Ngo, Tin C., et al.
Publicado: (2013) -
Clinical Value of Persistent but Downgraded Vesicoureteral Reflux after Dextranomer/Hyaluronic Acid Injection in Children
por: Baek, Minki, et al.
Publicado: (2013) -
New bulking agent for the treatment of vesicoureteral reflux: Polymethylmethacrylate/dextranomer
por: Kim, Sang Woon, et al.
Publicado: (2018) -
Endoscopic Treatment of Vesicoureteral Reflux in Children with Dextranomer/Hyaluronic Acid—A Single Surgeon's 6-Year Experience
por: Chen, Hou-Chuan, et al.
Publicado: (2010)